Nirmal Raut· @oncologician · X·· 1 天前评分45
正文 · 机器翻译
实体瘤肿瘤科医生现在不得不习惯“Izalontamab Brengitecan”这样的绕口药名，就像血液科医生念出“Axicabtagene ciloleucel”一样
#ESMO2026 @BalazsHalmosMD
16 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
Phase II study of izalontamab brengitecan (Iza-bren) plus osimertinib in patients with EGFR mutant locally advanced or metastatic non-small cell lung cancer (NSCLC)
https://esmocongress.esmo.orgLBA50按 Proffered paper 1: Breast cancer, early and advanced stage 对上
PANKU-Breast01: Randomized phase III study of izalontamab brengitecan (iza-bren) in previously treated unresectable locally advanced or metastatic (LA/M) hormone receptor-positive/HER2-negative (HR+/HER2-) breast cancer (BC)
https://esmocongress.esmo.org来源：Nirmal Raut · x.com